# GRANULES (GRANULES) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/granules

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹875.4
- Change: +0.57%
- As of: 2026-09-18
- 1D return: +0.59%
- 5D return: -2.64%
- 1M return: +4.03%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, Granules is trading above key moving averages across daily, weekly, and monthly timeframes, indicating a generally bullish technical stance. The daily trend shows the price above the 20-day and 50-day Exponential Moving Averages (EMAs) and Simple Moving Averages (SMAs), with a positive Supertrend signal. This alignment extends to the weekly and monthly views, where the price also remains above its respective EMAs, SMAs, and Supertrend indicators, suggesting a consistent upward trend across multiple periods. The stock is currently positioned around the middle of its 20-day and 50-day trading ranges.

Recent patterns include an active "Doji" on the daily chart and an "Outside Bar" on the weekly chart as of September 18, 2026, which can signal potential indecision or a shift in momentum. On September 11, 2026, an "upward" price move occurred with an "EXTREME" severity anomaly, accompanied by a high volume ratio of 9.08 on the daily timeframe. The stock's current price of ₹875.5 is approximately 0.8% below the nearest resistance level at ₹882.5 and 1.67% above the nearest support level at ₹860.87.

The stock exhibits an annualized volatility of 33% and a current drawdown of -4%. The nearest overhead resistance is observed at ₹882.5, with further levels at ₹883.53 and ₹896.67. Key support is identified at ₹860.87, followed by ₹847.73. Monitoring the price action around these levels will be crucial. A break above ₹882.5 could signal further upside, while a fall below ₹860.87 might indicate a short-term pullback.

- The stock's technical posture is bullish, with prices above key moving averages (20-day, 50-day, 200-day EMAs/SMAs) and Supertrend signals across daily, weekly, and monthly timeframes as of September 18, 2026.
- Nearest resistance is at ₹882.5 (0.8% above current price), with support at ₹860.87 (-1.67% below current price).
- Recent patterns include an active daily Doji and a weekly Outside Bar as of September 18, 2026.
- An upward price move on September 11, 2026, was associated with an "EXTREME" severity anomaly and a high daily volume ratio of 9.08.
- Watch for a sustained move above ₹882.5 or a break below ₹860.87 for potential shifts in the short-term trend.

- Outside Bar
- Doji
- Bearish Engulfing Reversal
- Bullish Engulfing Reversal

### News Context

On September 17, 2026, Krishna Prasad Chigurupati, a promoter of Granules India, sold a 7% stake, representing 1.72 crore shares, in the company. This transaction was reported as a move to raise ₹1,500 crore. Separately, Granules India was mentioned in market commentary on September 18 as a stock under 'Trade Spotlight', suggesting investor attention on its trading activity. The company was also listed among 'Buzzing stocks for Sept 17' due to various corporate activities across the Indian market.

- On September 17, 2026, promoter Krishna Prasad Chigurupati sold 1.72 crore shares (7% stake) of Granules India, raising ₹1,500 crore.
- Granules India was highlighted in 'Trade Spotlight' market commentary on September 18, 2026.
- The company was identified as a 'Buzzing stock' on September 17, 2026, amidst broader market activity.

- Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?
- Hyderabad Granules promoter sells 7% stake to raise 1.5k crore
- Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules, Fine Organic Chem, Venus Pipes, Highway Infra
- Stock market today: Trade guide for Sensex, Nifty 50, crude oil to gold | Eight stocks to buy
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun Beverages

### What Changed

As of September 18, 2026, a significant development for Granules India involved its promoter, Krishna Prasad Chigurupati, selling a 7% stake, amounting to 1.72 crore shares, to raise ₹1,500 crore. This transaction occurred against a backdrop of the company's stock trading at ₹875.5 on the observation date, a slight increase from its previous price of ₹870.4. The company, listed on the NSE under the symbol GRANULES, continues to be a subject of market discussion, as indicated by its inclusion in a "Trade Spotlight" article on the same date.

- On September 18, 2026, promoter Krishna Prasad Chigurupati sold 1.72 crore shares, representing a 7% stake in Granules India, to raise ₹1,500 crore.
- The stock price on September 18, 2026, was ₹875.5, compared to ₹870.4 previously.
- Granules India was featured in a "Trade Spotlight" article on September 18, 2026, alongside other listed companies.

- Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?
- Hyderabad Granules promoter sells 7% stake to raise 1.5k crore

### Official Filings

Granules India Limited has completed the conversion of warrants into equity shares for promoter group investors. On September 16, 2026, the company approved the allotment of 2,49,82,906 fully paid-up equity shares at ₹585 per share, following the receipt of the balance 75% subscription amount totaling ₹1,461.50 crores. This conversion increases the company's paid-up equity share capital. Separately, on September 11, 2026, a promoter, Dr. Krishna Prasad Chigurupati, sold 17,200,000 equity shares to fund the second tranche of the company's preferential issue. This sale reduced the promoter and promoter group's aggregate shareholding. The company indicated that funds from a prior preferential issue in February 2026 have been deployed faster than anticipated for growth initiatives. In other developments, the company reported strong Q1 FY27 earnings with revenue up 22% year-on-year to INR 1,477 crores, EBITDA up 37% to INR 339 crores, and profit after tax up 60% to INR 180 crores. The company also noted significant progress in facility remediation, with 7 out of 8 facilities carrying a clean EIR. A change in management was also noted, with Mr. Sanjay Kumar transferring from Chief Strategy Officer to CEO of a wholly owned subsidiary, Ascelis Peptides Private Limited, effective August 13, 2026.

- On September 16, 2026, 2,49,82,906 equity shares were allotted to promoter group investors upon conversion of warrants, with a total consideration of ₹1,461.50 crores received.
- On September 11, 2026, promoter Dr. Krishna Prasad Chigurupati sold 17,200,000 equity shares to fund a preferential issue, reducing promoter shareholding.
- Q1 FY27 results reported on July 27, 2026, showed a 22% year-on-year revenue growth to INR 1,477 crores and a 60% increase in profit after tax to INR 180 crores.
- On August 13, 2026, Mr. Sanjay Kumar was transferred to become CEO of a wholly owned subsidiary, Ascelis Peptides Private Limited, following his resignation as Chief Strategy Officer.
- Remediation work at the Gagillapur facility is nearing completion, with 7 of 8 facilities having a clean EIR as of July 27, 2026.

- Granules India Limited has informed the Exchange about Conversion |SUBJECT: Conversion
- Granules India Limited has informed the Exchange regarding 'Update'. |SUBJECT: Updates
- Granules India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Granules India Limited has informed the Exchange regarding 'Update'. |SUBJECT: Updates
- Granules India Limited has informed the Exchange about change in Management |SUBJECT: Change in Management
- GRANULES INDIA LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
- Granules India Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP

### Fundamentals

Granules India's recent operating performance shows a mixed trajectory. For the quarter ending March 2024, the company reported Sales of ₹1,176 crore and an Operating Profit of ₹256 crore, resulting in an Operating Profit Margin (OPM) of 22.0%. This was followed by a sequential decline in Sales to ₹967 crore in Q2 FY25, with Operating Profit at ₹203 crore and OPM at 21.0%. Looking ahead, projections for Q3 FY26 indicate Sales of ₹1,387.94 crore and an Operating Profit of ₹247 crore, with an OPM of 20.0%. Net Profit for March 2024 was ₹130 crore, with an Earnings Per Share (EPS) of ₹5.35. Projections suggest Net Profit could reach ₹152 crore in March 2025 and ₹202 crore in March 2026, with corresponding EPS of ₹6.27 and ₹8.13.

Financially, the company's borrowings have increased from ₹1,106 crore in March 2022 to ₹1,315 crore in March 2024. Fixed Assets have also grown from ₹1,541 crore to ₹2,096 crore over the same period, indicating investment in infrastructure. The Cash Flow from Operations has fluctuated, standing at ₹439 crore for March 2024, down from ₹739 crore in March 2023. Free Cash Flow was ₹61 crore in March 2024, a decrease from ₹328 crore in March 2023. The Cash Conversion Cycle has lengthened from 156 days in March 2022 to 179 days in March 2024, driven by an increase in Inventory Days from 190 to 235 days.

Key monitoring areas include the trend in operating margins, the conversion of operating profit into net profit, and the management of working capital, particularly inventory levels. The increasing trend in borrowings and the fluctuating cash flow from operations warrant attention.

- For the quarter ending March 2024, Granules India reported Sales of ₹1,176 crore and Operating Profit of ₹256 crore (OPM 22.0%).
- Projected Sales for Q3 FY26 are ₹1,387.94 crore, with Operating Profit at ₹247 crore (OPM 20.0%).
- Net Profit for March 2024 was ₹130 crore (EPS ₹5.35), with projections for March 2026 Net Profit at ₹202 crore (EPS ₹8.13).
- Borrowings increased from ₹1,106 crore in March 2022 to ₹1,315 crore in March 2024.
- The Cash Conversion Cycle increased to 179 days in March 2024 from 156 days in March 2022, primarily due to higher Inventory Days.

### Bull Case

Granules India's financial performance shows positive trends in sales and profit growth over the Trailing Twelve Months (TTM) period. The company has demonstrated an increase in cash flow from operations and has generated free cash flow in the most recent fiscal year. Technically, the stock exhibits a bullish trend across daily, weekly, and monthly timeframes, supported by moving averages and trend indicators.

- Compounded sales growth was 25% for the TTM period and 11% over 5 years.
- Compounded profit growth was 36% for the TTM period.
- Cash flow from operations increased to ₹476.0 in March 2020 from ₹262.0 in March 2019.
- Free Cash Flow was ₹292.0 in March 2020, compared to -₹17.0 in March 2019.
- Technical indicators show a bullish trend on daily, weekly, and monthly charts as of September 18, 2026.

- Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?
- Hyderabad Granules promoter sells 7% stake to raise 1.5k crore
- Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules, Fine Organic Chem, Venus Pipes, Highway Infra
- Stock market today: Trade guide for Sensex, Nifty 50, crude oil to gold | Eight stocks to buy
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun Beverages

### Bear Case

Granules India's balance sheet shows a decrease in borrowings from ₹991 crore in March 2019 to ₹892 crore in March 2020. However, this reduction was accompanied by an increase in fixed assets from ₹944 crore to ₹1,204 crore and other assets from ₹1,328 crore to ₹1,706 crore over the same period. Investments saw a significant drop from ₹210 crore to ₹19 crore. Cash flow from financing activities was negative ₹213 crore in March 2020, compared to negative ₹17 crore in March 2019, indicating a higher outflow related to financing. While cash flow from operations increased to ₹476 crore in March 2020 from ₹262 crore in March 2019, and free cash flow turned positive at ₹292 crore from a negative ₹17 crore, the company's reliance on financing activities for cash needs to be monitored.

- Borrowings decreased by ₹99 crore from ₹991 crore (Mar 2019) to ₹892 crore (Mar 2020).
- Fixed assets increased by ₹260 crore from ₹944 crore (Mar 2019) to ₹1,204 crore (Mar 2020).
- Investments decreased by ₹191 crore from ₹210 crore (Mar 2019) to ₹19 crore (Mar 2020).
- Cash from financing activities was negative ₹213 crore in Mar 2020, a significant increase from negative ₹17 crore in Mar 2019.

- Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?
- Hyderabad Granules promoter sells 7% stake to raise 1.5k crore
- Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules, Fine Organic Chem, Venus Pipes, Highway Infra
- Stock market today: Trade guide for Sensex, Nifty 50, crude oil to gold | Eight stocks to buy
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun Beverages

### FAQs

**What was the recent change in Granules India's shareholding structure due to a promoter's sale of shares?**

On September 11, 2026, promoter Dr. Krishna Prasad Chigurupati sold 17,200,000 equity shares. This sale was conducted via a block deal and open market transactions to fund the second tranche of the company's preferential issue. The transaction reduced the aggregate shareholding of the promoter and promoter group from 38.02% to 31.08% of the paid-up equity capital. Dr. Chigurupati's individual holding decreased from 31.00% to 24.06%.

**How has Granules India's cash flow from operations and free cash flow changed between March 2019 and March 2020?**

Granules India's cash flow from operating activities increased to ₹476.0 crore in March 2020 from ₹262.0 crore in March 2019. Consequently, free cash flow improved to ₹292.0 crore in March 2020, compared to a negative ₹17.0 crore in March 2019. Cash flow from operations (CFO/OP) also saw an increase to 113.0 in March 2020 from 91.0 in March 2019.

**What recent corporate actions have impacted Granules India's equity share capital?**

On September 15, 2026, promoter group members paid the remaining 75% subscription amount of ₹1,093 crore for convertible warrants. This made 2,49,14,530 warrants fully paid and eligible for conversion. Subsequently, on September 16, 2026, the company approved the allotment of 2,49,82,906 equity shares at ₹585 per share, totaling ₹1,461.50 crore, pursuant to the conversion of these warrants. This increased the paid-up equity share capital.

**What are the recent trends in Granules India's sales and profit growth?**

Granules India has shown growth in both sales and profit. Over the last 5 years, the compounded sales growth was 11%, and for the Trailing Twelve Months (TTM), it was 25%. Compounded profit growth over 5 years was 2%, with a significant increase to 36% for the TTM period.

- Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?
- Hyderabad Granules promoter sells 7% stake to raise 1.5k crore
- Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules, Fine Organic Chem, Venus Pipes, Highway Infra
- Stock market today: Trade guide for Sensex, Nifty 50, crude oil to gold | Eight stocks to buy
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun Beverages
- Granules India Limited has informed the Exchange about Conversion |SUBJECT: Conversion
- Granules India Limited has informed the Exchange regarding 'Update'. |SUBJECT: Updates
- Granules India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Granules India Limited has informed the Exchange regarding 'Update'. |SUBJECT: Updates
- Granules India Limited has informed the Exchange about change in Management |SUBJECT: Change in Management
## Technical analytics

- As of: 2026-09-18
- Daily trend: Weak Uptrend
- Weekly trend: Moderate Uptrend
- Pivot point: ₹860.87
- Risk regime: Price Risk Requires Attention

### Support levels
- 823.925
- 566.75
- 556.46875

### Resistance levels
- 882.5
- 916.825
- 883.5333333333333

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | +0.59% |
| return_10 | +2.54% |
| return_1m | +2.85% |
| return_1y | +61.19% |
| return_20 | +4.03% |
| return_3m | +11.94% |
| return_5 | -2.64% |
| return_6m | +49.11% |
| return_since_start | +46.55% |
| return_ytd | +41.39% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -30.03% |
| annualized_volatility | +32.52% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue edges to new high, but profit declines sequentially despite sharp drop in finance costs

Granules India reported revenue of ₹1,476.77 crore for the June 2026 quarter, a marginal 0.4% increase from the preceding quarter and a 22% rise from the same period last year. Profit before tax fell 8.4% sequentially to ₹240.40 crore, even as finance costs dropped 35%. Net profit declined 10.7% to ₹179.96 crore, with the effective tax rate rising to 25.1% from 23.2%. Year-over-year, profit grew significantly, reflecting improved margins.

## Revenue Growth Slows Sequentially

Revenue has risen steadily over the past four quarters, from ₹1,210.11 crore in Q1 FY2025-26 to ₹1,470.61 crore in Q4 FY2025-26. The latest quarter’s increase to ₹1,476.77 crore represents a sequential growth of only 0.4%, a marked deceleration from the 6–7% growth rates seen in the previous three quarters. The year-over-year growth of 22% is substantial, but the near-flat sequential movement suggests a pause in the revenue momentum.

## Profit Declines Despite Lower Finance Costs

Profit before tax fell from ₹262.36 crore in Q4 FY2025-26 to ₹240.40 crore in Q1 FY2026-27, a decline of 8.4%. Net profit dropped from ₹201.57 crore to ₹179.96 crore, a decline of 10.7%. This occurred even as finance costs decreased sharply from ₹32.69 crore to ₹21.12 crore, a 35% reduction. Other expenses increased marginally from ₹373.94 crore to ₹375.48 crore. The effective tax rate also increased from 23.2% to 25.1%, further reducing net profit. As a result, the net profit margin fell from 13.7% in Q4 to 12.2% in Q1.

## Year-over-Year Performance

Compared to Q1 FY2025-26, revenue grew 22%, profit before tax grew 66%, and net profit grew 60%. This indicates that the company has significantly improved its profitability over the past year. Basic earnings per share rose from ₹4.64 to ₹7.26, a 56% increase. The net profit margin improved from 9.3% in Q1 FY2025-26 to 12.2% in the current

### Ratios

## Official filings

- 2026-09-16 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_16092026174159_NSEBSE.pdf)
- 2026-09-15 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_15092026194521_NSEBSE15092026.pdf)
- 2026-09-11 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_11092026154134_LetterHead.pdf)
- 2026-09-11 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_11092026183839_NSEBSE11092026.pdf)
- 2026-08-13 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_13082026141701_NSEBSE.pdf)
- 2026-08-13 — Generic Announcement: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_2296_WebXMLFile_20260813_145129486.xml)
- 2026-08-13 — Management Change: Granules India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_ROID_96256_KMP_Doc.zip)
- 2026-08-06 — Generic Announcement: Granules India Limited held its 35th Annual General Meeting on August 6, 2026, via video conferencing. The meeting transacted ordinary business, including the adoption of audited financial statements for FY 2025-26, the declaration of a final dividend of Rs. 1.75 per equity share, and the re-appointment of Ms. Priyanka Chigurupati. All resolutions were passed with the requisite majority, as confirmed by the consolidated scrutinizer's report. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_06082026163635_NSEBSEOUTCOMEFINAL.pdf)
- 2026-07-27 — Generic Announcement: Granules India Limited reported its Q1 FY27 earnings, with revenue growing 22% year-on-year to INR 1,477 crores. EBITDA increased by 37% to INR 339 crores, and profit after tax grew by 60% to INR 180 crores. The company's return on capital improved to 18%, and net debt to EBITDA is now 0.07x, indicating a near debt-free status. The company also noted that remediation work at its Gagillapur facility is essentially complete, with 7 of 8 facilities carrying a clean EIR, and 9 applications are ready for launch pending FDA clearance. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_27072026120801_NSEBSE27072026.pdf)
- 2026-07-22 — Generic Announcement: Granules India Limited has uploaded the audio recording of its Q1 FY27 earnings conference call to its website on July 22, 2026. This action complies with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_22072026074724_AUDIORECORDINGNSEBSE.pdf)
- 2026-07-21 — Press Release: Granules India Limited reported Q1 FY27 results on July 21, 2026, with revenue from operations at INR 14,768 million, a 22% year-over-year increase. EBITDA rose 37% YoY to INR 3,389 million, and Profit After Tax (PAT) increased 60% YoY to INR 1,800 million. Revenue from North America was 72% and Europe was 16% in Q1FY27. Net debt reduced by INR 8,467 million from Q1FY26 to INR 1,012 million. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_21072026123641_NSEBSEPR.pdf)
- 2026-07-21 — Generic Announcement: Granules India Limited has informed the Exchange about Presentation |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_21072026123939_NSEBSEINVESTORPRES.pdf)
- 2026-07-21 — Generic Announcement: Granules India Limited submitted its Monitoring Agency Report for the quarter ended June 30, 2026, to the National Stock Exchange of India Limited and BSE Limited. The report, issued by India Ratings & Research Private Limited, confirms no deviation from the objects for the utilization of proceeds from a preferential issue. The total issue size was INR 1,762.50 Crores, with INR 665.63 Crores received and INR 218.14 Crores utilized as of June 30, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_21072026141536_NSEBSEMAREPORT.pdf)
- 2026-07-21 — Generic Announcement: Granules India Limited's Board of Directors approved the unaudited financial results for the first quarter ended June 30, 2026, on July 21, 2026. The standalone results show total income of Rs. 8,156.61 million and a profit of Rs. 717.46 million for the quarter. The consolidated results indicate total income of Rs. 14,790.41 million and a profit of Rs. 1,799.63 million for the same period. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_21072026121208_NSEBSEOUTCOME.pdf)
- 2026-07-16 — Generic Announcement: Granules India Limited published a newspaper advertisement on July 16, 2026, in Business Standard and Nava Telangana regarding the notice of its 35th Annual General Meeting and e-voting information. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_16072026113025_NSEBSENEWSPAPER.pdf)
- 2026-07-15 — Generic Announcement: Granules India Limited submitted its Integrated Annual Report for FY 2025-26 on July 15, 2026, along with the notice for its 35th Annual General Meeting scheduled for August 6, 2026. The report details the company's financial performance, including revenue of ₹53,656 million (a 20% year-on-year increase) and EBITDA of ₹11,851 million (a 25% increase). It also highlights strategic progress in areas such as complex generics, peptide therapeutics through the acquisition of Senn Chemicals AG, and sustainability initiatives, including achieving an EcoVadis Gold rating and a CDP Climate Change score of 'A'. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_15072026121359_NSEBSEANNUALREPORT.pdf)
- 2026-07-09 — Official Filing: Granules India Limited will hold a board meeting on July 21, 2026, to consider unaudited standalone and consolidated financial results for the quarter ended June 2026. The trading window for the company's securities will be closed from July 1, 2026, to July 23, 2026.
- 2026-07-09 — Generic Announcement: Granules India Limited will hold an earnings conference call for Q1 of FY27 on Tuesday, July 21, 2026, at 5:00 PM IST. The call will discuss the company's financial performance and business updates. Key management personnel, including the Chairman & MD, Executive Director, CFO, CTO, and Chief Strategy Officer, will participate. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_09072026104848_NSEBSEEARNINGCALL.pdf)
- 2026-07-06 — Press Release: Granules India Limited announced on July 6, 2026, that it has secured Sole First-to-File (FTF) status for its Abbreviated New Drug Application (ANDA) for Sodium Oxybate Extended-Release for Oral Suspension, the generic equivalent of LUMRYZ® extended-release oral suspension. This marks Granules' second Sole FTF ANDA, following a previous success with Amphetamine Extended-Release Tablets. The company views this as a significant milestone in its complex generics journey, highlighting its R&D and regulatory capabilities. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_06072026083907_NSEBSE06072026.pdf)
- 2026-06-25 — Generic Announcement: Granules India Limited will close its trading window for dealing in the company's securities from July 01, 2026, until 48 hours after the declaration of the un-audited financial results for the first quarter of FY 27 ending June 30, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the company's code of conduct. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_25062026114158_NSEBSEWINDOW.pdf)
- 2026-06-15 — Generic Announcement: Granules India Limited will participate in the IIFL Invest India Conference in London on June 23-24, 2026. Company officials will hold one-to-one and group meetings with analysts and investors. The schedule is tentative and no unpublished price-sensitive information will be disclosed. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_15062026103618_NSEBSEIIFL.pdf)
- 2026-06-03 — Press Release: Granules India Limited announced that its wholly-owned subsidiary, Granules Pharmaceuticals, Inc. (GPI), received an Establishment Inspection Report (EIR) from the US FDA for its Chantilly, Virginia facility. The EIR classified the facility as Voluntary Action Indicated (VAI) following an inspection conducted from March 30 to April 3, 2026, during which four Form 483 observations were issued. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_03062026114409_NSEBSEPR.pdf)
- 2026-05-28 — Generic Announcement: Granules India Limited will hold a meeting with Analysts/Investors/Funds on June 03, 2026, in Hyderabad. The company will not share any unpublished price-sensitive information during these meetings. The schedule is tentative and subject to change. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_28052026163848_Investor_meet.pdf)
- 2026-05-28 — Generic Announcement: Granules India Limited responded to the National Stock Exchange of India on May 28, 2026, regarding a recent spurt in trading volume. The company stated that all necessary price-sensitive information has been disclosed in a timely manner as per SEBI Listing Regulations, 2015. Granules India Limited attributes the increase in security volume to market-driven factors. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_28052026101510_NSEREPLYFORSPURT.pdf)
- 2026-05-05 — Generic Announcement: Granules India Limited held an earnings conference call on May 5, 2026, to discuss Q4 and the full financial year ending March 31, 2026. The company reported FY26 revenue of INR 53,656 million, a 20% year-on-year increase, with finished dosages contributing 74% and the peptide CDMO business adding INR 1,593 million. The company achieved a gross margin of 65% and an EBITDA margin of 22.1% for FY26. Key developments included the GPI facility in Virginia reaching targeted operating potential, the acquisition of Senn representing strategic expansion into the CDMO segment with positive EBITDA in Q3 post-acquisition, and progress in regulatory remediation activities, including successful inspections at key sites. The company plans for FY27 include achieving sustained U.S. FDA readiness at Gagillapur, scaling commercial contributions from GLS, and accelerating the shift towards complex products, with an estimated capex of around INR 600 crores. — [Official attachment](https://nsearchives.nseindia.com/corporate/GRANULES_05052026152133_NSEBSETRANSCRIPT.pdf)

## News and market events

- 2026-09-18 — MONEYCONTROL: **Trade Spotlight: How should you trade Castrol, Ramkrishna Forgings, Sapphire Foods, Jindal Saw, Granules India, and others on September 18?** — Trade Spotlight — [Source](https://www.moneycontrol.com/news/business/markets/trade-spotlight-how-should-you-trade-castrol-ramkrishna-forgings-sapphire-foods-jindal-saw-granules-india-and-others-on-september-18-14032566.html)
- 2026-09-17 — Times of India: **Hyderabad Granules promoter sells 7% stake to raise 1.5k crore** — HYDERABAD: Krishna Prasad Chigurupati, the promoter of Hyderabad-based Granules India, offloaded a nearly 7% (1.72 crore shares) stake in the company . — [Source](https://timesofindia.indiatimes.com/city/hyderabad/hyderabad-granules-promoter-sells-7-stake-to-raise-1-5k-crore/articleshow/134318489.cms)
- 2026-09-17 — The Hindu: **Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules,  Fine Organic Chem, Venus Pipes, Highway Infra** — Several Indian companies, including Reliance and Infosys, are making significant moves, from fundraising to new facilities, highlighting a dynamic shift in the corporate landscape — [Source](https://www.thehindubusinessline.com/markets/buzzing-stocks-for-sept-17-reliance-infosys-krsnaa-mazagon-dock-motilal-oswal-granules-fine-organic-chem-venus-pipes-highway-infra/article71475140.ece)
- 2026-09-15 — Mint: **Stock market today: Trade guide for Sensex, Nifty 50, crude oil to gold | Eight stocks to buy** — Indian stock market indices, Sensex and Nifty 50, are set to open higher on 15 September amid mixed global signals. Sensex and Nifty ended lower previously, but GIFT Nifty shows a positive start. Crude oil prices remain a concern for market stability. — [Source](https://www.livemint.com/market/stock-market-news/stock-market-today-trade-guide-for-sensex-nifty-50-crude-oil-to-gold-eight-stocks-to-buy-11789434902080.html)
- 2026-09-15 — Economic Times: **Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun Beverages** — On September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracted selective buying, which limited the days overall losses. Major players like HDFC Bank and IT sectors remained in focus amid relevant corporate announcements. Additionally, SEBI's discussion paper regarding the Closing Auction Session received input on five critical areas. — [Source](https://economictimes.indiatimes.com/markets/stocks/news/stocks-in-news-hdfc-bank-coforge-hfcl-sun-pharma-and-varun-beverages/articleshow/134245046.cms)
- 2026-09-15 — Mint: **Stock recommendations for 15 September from MarketSmith India** — MarketSmith India reveals its top stock recommendations for today, 15 September. Get expert insights into the best-performing stocks to guide your investment decisions. — [Source](https://www.livemint.com/market/stock-market-news/stock-recommendations-for-15-september-from-marketsmith-india-11789129589490.html)
- 2026-09-14 — CNBC-TV18: **Stocks to Watch for September 15: HDFC Bank, BSE, IT Stocks, Coforge, Tata Chemicals and more** — From HDFC Bank's succession plan to Tata Sons' potential listing and its impact on listed Tata Group stocks and the impact of SEBI's consultation paper on CAS on BSE, Angel One and other brokers, these are the stocks you should watch out for going into Tuesday's trading session. — [Source](https://www.cnbctv18.com/photos/market/stocks-to-watch-for-september-15-hdfc-bank-bse-angel-one-tata-group-infosys-tcs-raymond-share-price-19989980.htm)
- 2026-09-11 — BUSINESS: **Paytm stock soars to post-listing record, yet below IPO price** — Paytm parent One97 Communications hit a post-listing record high of ₹1,807.5, while Granules India promoter Krishna Prasad Chigurupati offloaded a 6.95% stake for ₹1,501 crore in block deals — [Source](https://www.business-standard.com/markets/stock-market-news/paytm-stock-soars-to-post-listing-record-yet-below-ipo-price-126091101561_1.html)
- 2026-09-11 — MONEYCONTROL: **Granules India promoter offloads shares worth Rs 1,509 crore; Morgan Stanley picks stake in Lotus Developers** — Sri Lotus Developers and Realty,Granules India,Block Deals — [Source](https://www.moneycontrol.com/news/business/markets/granules-india-promoter-offloads-shares-worth-rs-1-509-crore-morgan-stanley-picks-stake-in-lotus-developers-14028183.html)
- 2026-09-11 — BUSINESS: **Volumes soar at Authum Investment & Infrastructure Ltd counter** — Authum Investment & Infrastructure Ltd recorded volume of 48.96 lakh shares by 14:14 IST on NSE, a 10.41 times surge over two-week average daily volume of 4.70 lakh shares — [Source](https://www.business-standard.com/markets/capital-market-news/volumes-soar-at-authum-investment-infrastructure-ltd-counter-126091100742_1.html)
- 2026-09-11 — CNBC-TV18: **11:11 | Putin in India for BRICS Summit; oil crosses $108; rupee slips** — Russian President Vladimir Putin arrives in New Delhi for the BRICS Summit and talks with PM Modi, as the capital tightens security for the three-day gathering. Meanwhile, Brent crude crosses $108 a barrel, the rupee slips to ₹95.69 and Anthropic disrupts suspected Russian, Chinese AI campaigns — plus more in today’s 11:11 roundup. — [Source](https://www.cnbctv18.com/business/putin-in-india-for-brics-summit-oil-prices-surge-rupee-slips-19989023.htm)
- 2026-09-11 — MONEYCONTROL: **Granules India block deal: 5.3% equity worth Rs 1,160 crore changes hands; promoter likely seller** — granules India block deal, granules India equity stake sale, granules India promoter stake sale, granules India share sale, granules India large trade, granules India share price today, granules India stock update — [Source](https://www.moneycontrol.com/news/business/markets/granules-india-block-deal-5-3-equity-worth-rs-1-160-crore-changes-hands-promoter-likely-seller-14027644.html)
- 2026-09-11 — Mint: **Buy or sell Granules, HAL, HUL shares? Ajit Mishra of Religare Broking suggests trading strategies for these stocks** — Ajit Mishra from Religare Broking shares crucial trading strategies for Granules India, Hindustan Aeronautics Limited (HAL), and Hindustan Unilever Limited (HUL). Discover whether to buy or sell based on current market dynamics and projections. — [Source](https://www.livemint.com/market/stock-market-news/buy-or-sell-granules-hal-hul-shares-ajit-mishra-of-religare-broking-suggests-trading-strategies-for-these-stocks-11789096708131.html)
- 2026-09-10 — The Hindu: **Women’s workforce participation rises, but funding and leadership gaps remain** — Women’s workforce participation rises, but funding and leadership gaps remain — [Source](https://www.thehindu.com/news/national/telangana/womens-workforce-participation-rises-but-funding-and-leadership-gaps-remain/article71452397.ece)
- 2026-09-09 — MONEYCONTROL: **Trade Spotlight: How should you trade Marico, Narayana Hrudayalaya, Granules, Laurus Labs, Caplin Point, Tata Technologies, and others on September 9?** — Trade Spotlight — [Source](https://www.moneycontrol.com/news/business/markets/trade-spotlight-how-should-you-trade-marico-narayana-hrudayalaya-granules-laurus-labs-caplin-point-tata-technologies-and-others-on-september-9-14025670.html)
- 2026-08-10 — Mint: **Raja Venkatraman recommends three stocks for 10 August** — Market expert Raja Venkatraman shares his top stock picks for 10 August. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-three-stocks-10-august-grasim-industries-ltm-granules-india-nifty-sensex-11786192134319.html)
- 2026-07-24 — Economic Times: **Dixon Technologies, Paras Defence among 14 new stocks added by this one-year topper mutual fund in June** — TRUSTMF Small Cap Fund, the best-performing equity mutual fund over the past one year with a 21.98% return, added Dixon Technologies (India), Paras Defence and Space Technologies and 14 other stocks to its portfolio in June. The fund also exited 13 stocks while increasing exposure to several others, according to its latest monthly factsheet. — [Source](https://economictimes.indiatimes.com/mf/analysis/dixon-technologies-paras-defence-among-14-new-stocks-added-by-this-one-year-topper-mutual-fund-in-june/articleshow/132597567.cms)
- 2026-07-23 — CNBC-TV18: **Why Indian pharma stocks aren't panicking yet over Trump's proposed tariffs on generic drugs** — Indian drugmakers supply about 40% of the generic medicines imported by the US, making Trump's proposed tariffs a major risk. But a delayed rollout, existing US factories and other factors are keeping investors from hitting the panic button. — [Source](https://www.cnbctv18.com/market/why-indian-pharma-stocks-are-not-panicking-over-trump-tariffs-19952485.htm)
- 2026-07-23 — The Hindu: **Sensex today | Stock Market Live: Sensex down 390 pts at open, Nifty at 23,900 as Brent Crude surges past $96** — Sensex, Nifty, Share Prices LIVE: At 9:16 am, Sensex dropped 348.13  points (-0.45%) to 76,406.92, Nifty shed 91.45 points (-0.38%) to 23,904.80 — [Source](https://www.thehindubusinessline.com/markets/sensex-nifty50-today-stock-market-live-updates-23-july-2026/article71253376.ece)
- 2026-07-23 — Economic Times: **Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investors** — Indian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact companies with substantial US revenue exposure. Analysts suggest investors should now focus on domestically oriented Indian pharmaceutical firms. The Nifty Pharma index saw a notable decrease, while the benchmark Nifty 50 also fell. Negotiations are expected given India's vital role in supplying affordable medicines to the US. — [Source](https://economictimes.indiatimes.com/markets/stocks/news/pharma-stocks-slide-as-trumps-100-generic-drug-tariff-plan-spooks-investors/articleshow/132570049.cms)
- 2026-07-22 — The Hindu: **Trump’s 200% generic tariff threat would imperil Americans: Indian pharma** — Trump mandates U.S. generic drug production by 2028, imposing escalating tariffs on imports to boost domestic manufacturing. — [Source](https://www.thehindu.com/business/make-in-us-by-august-2028-or-pay-up-to-200-duty-trump-tells-generic-drugmakers/article71254793.ece)
- 2026-07-22 — The Hindu: **Make in U.S. by August 2028 or pay up to 200% duty, Trump tells generic drugmakers** — Trump mandates U.S. generic drug production by 2028, imposing escalating tariffs on imports to boost domestic manufacturing. — [Source](https://www.thehindu.com/news/international/make-in-us-by-august-2028-or-pay-up-to-200-duty-trump-tells-generic-drugmakers/article71254793.ece)
- 2026-07-22 — CNBC-TV18: **Sensex Today | Stock Market LIVE Updates: Nifty falls below 24,000 mark as market extends losses** — Sensex Today | Stock Market LIVE Updates: The markets are under immense pressure, with the Nifty index falling over 150 points, slumping towards 24,000. The Nifty Bank is down over 500 points, slumping towards 57,300. IndiGo, Cipla and and SBI are the top laggards. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-crude-bandhan-drl-adani-nestle-hpcl-eternal-bpcl-share-price-liveblog-19950949.htm)
- 2026-07-22 — CNBC-TV18: **Q1 Results LIVE Updates: Dr. Reddy's, Eternal, HPCL report today; Cyient DLM, JSW Infra react** — Q1 Results LIVE Updates: Three Nifty 50 companies, Eternal, Dr. Reddy's Laboratories and Nestle India, are reporting their earnings today. dani Green Energy, BPCL, Adani Power, CIE Automotive, CSB Bank, Waterways Leisure Tourism, HEG, HPCL, HFCL, IIFL Finance, JSW Energy, IndusInd Bank, United Spirits are among the other results scheduled for today. Also watch for result reactions from stocks like Bandhan Bank, JSW Infra, Indian Hotels and many others. Watch this space for all the LIVE updates. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-eternal-dr-reddys-hpcl-bpcl-indusind-bank-csb-adani-heg-iifl-fin-jsw-indian-hotels-indiamart-cyient-dlm-share-price-liveblog-19950958.htm)
- 2026-07-21 — CNBC-TV18: **Q1 Results Highlights: Indian Hotels net profit rises 21%; Sunteck Realty EBITDA jumps 39%** — Q1 Results Highlights: Nifty 50 company Bajaj Auto reported its earnings today. TVS Motor, M&M Financial, Aavas Financiers, Indian Hotels, AB Sun Life AMC, Adani Energy, Arvind Fashions, Bandhan Bank, Adani Total Gas, Canara Robeco AMC, Cyient DLM, Crisil, Gabriel India, Hatsun Agro, Granules India, IndiaMART, Mastek, JSW Infrastructure, NIIT, MedPlus Health, Sagility, Sunteck Realty, Welspun Specialty and Trident were among the other companies that reported their June quarter results during the day. Paytm, Canara HSBC Life and others also remained in focus following their earnings. This live blog tracked all the key Q1 updates throughout the session — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-bajaj-auto-paytm-tvs-mm-fin-bandhan-indian-hotels-adani-rallis-indiamart-cyient-dlm-share-price-liveblog-19950068.htm)

## Business profile

**Strategic vision:** Vertically integrated pharmaceutical company manufacturing APIs, PFIs, and FDs.

### Business segments
- **Active Pharmaceutical Ingredients (API):** Granules India is a manufacturer of first-line defense APIs, including paracetamol, metformin, ibuprofen, guaifenesin, and methocarbamol.
- **Pharmaceutical Formulation Intermediates (PFI):** The company pioneered the commercialization of PFIs for large-volume drugs within the pharmaceutical value chain.
- **Finished Dosages (FD):** Granules India provides multiple finished dosage forms, such as tablets, caplets, and press-fit capsules, offered in bulk, blister packs, and bottles.
- **Oncology Therapeutic Segment:** Granules India has expanded its portfolio by venturing into the Oncology Therapeutic segment, where it develops APIs that are forward-integrated into finished dosages.

### Competitive strengths
- Vertically integrated pharmaceutical manufacturing capabilities.
- Focus on cost-effective product development through R&D.
- Expansion into specialized therapeutic segments like Oncology.
- Development of advanced drug delivery systems.

## Related stocks

- [ABBOTINDIA (Healthcare)](https://faxioms.com/stocks/abbotindia) — +5.50%
- [ACUTAAS (Healthcare)](https://faxioms.com/stocks/acutaas) — +3.86%
- [AJANTPHARM (Healthcare)](https://faxioms.com/stocks/ajantpharm) — +1.61%
- [ALKEM (Healthcare)](https://faxioms.com/stocks/alkem) — +0.14%
- [ANTHEM (Healthcare)](https://faxioms.com/stocks/anthem) — -0.35%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/granules
Markdown representation: https://faxioms.com/stocks/granules?render=md